St. Vincent Healthcare

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Kidney cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Eli Lilly and Company1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT05785767· Phase 2/3· Regeneron Pharmaceuticals· Source

Closed trials

• Recruiting

  A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  NCT06246916· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Completed

  A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

  NCT06192108· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· Phase 3· Pfizer· Source